- The key vendors in the API Market in India 2015-2019 are Aurobindo Pharma Ltd., Cipla Ltd. and Dr. Reddy’s Laboratories Ltd.
London, 07 January 2015: TechNavio, an independent tech-focused global research firm, has announced the publication of its market research report on the API Market in India 2015-2019. One major trend emerging in this market is the strong focus on the development and introduction of high-potency API. Such products are increasingly used in oncology and for the provision of targeted therapy. The API market in India is expected to witness a CAGR of 10.76 percent during the forecast period of 2014-2019.
Several pharmaceutical companies are outsourcing the manufacture of API to low-cost vendors in India, thus contributing to the growth of the market. The expiry of patents of blockbuster drugs and a strong focus on the development of high-potency API are other factors expected to drive the market.
“The API market in India is expected to witness strong focus on the development and commercialization of high-potency API by key vendors,” says Faisal Ghaus, Vice President of TechNavio Research.
“Demand for these products is substantial and is expected to be strong during the forecast period because of an increase in the application of targeted therapy for treatment of diseases”
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
